Hypocalcemia in the critically ill patient

Journal of Intensive Care Medicine

Volumn 28, Issue 3, 2013, Pages 166-177

  Kelly, Andrea ^a   Levine, Michael A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

critical illness; hypocalcemia; sepsis

Indexed keywords

ALKALINE PHOSPHATASE; AMINOGLYCOSIDE; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM CHLORIDE; CALCIUM ION; CALCIUM PHOSPHATE; CINACALCET; CISPLATIN; COLECALCIFEROL; DIGITALIS; DIURETIC AGENT; EDETIC ACID; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; FLUORIDE; FLUOROURACIL; FOLINIC ACID; FOSCARNET; GLUCONATE CALCIUM; PARATHYROID HORMONE; PHENOBARBITAL; PHENYTOIN; PHOSPHATE; THYROTROPIN; TRANSCRIPTION FACTOR GATA 3; VITAMIN D;

ALKALOSIS; ALOPECIA; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CONGESTIVE HEART FAILURE; CRITICALLY ILL PATIENT; DRY SKIN; EXAMINATION; HUMAN; HYDROXYLATION; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; INTENSIVE CARE; IRRITABILITY; OBESITY; OSSIFICATION; OSTEOBLAST; OSTEOMALACIA; PANCREATITIS; PAPILLEDEMA; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

CRITICAL ILLNESS; HYPOCALCEMIA; SEPSIS;

ACID-BASE EQUILIBRIUM; ADULT; CALCIUM; CALCIUM COMPOUNDS; CRITICAL CARE; CRITICAL ILLNESS; ENDOCRINE SYSTEM DISEASES; HOMEOSTASIS; HUMANS; HYPOALBUMINEMIA; HYPOCALCEMIA;

EID: 84877975513     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066611411543     Document Type: Review

References (120)

1. Cardenas-Rivero N, Chernow B, Stoiko MA, Nussbaum SR, Todres ID. Hypocalcemia in critically ill children. J Pediatr. 1989 ; 114 (6). 946-951
2. Chernow B, Zaloga G, McFadden E, et al. Hypocalcemia in critically ill patients. Crit Care Med. 1982 ; 10 (12). 848-851
3. Desai TK, Carlson RW, Geheb MA. Hypocalcemia and hypophosphatemia in acutely ill patients. Crit Care Clin. 1987 ; 3 (4). 927-941
4. Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis. 2001 ; 37 (4). 689-698
5. Aderka D, Schwartz D, Dan M, Levo Y. Bacteremic hypocalcemia. A comparison between the calcium levels of bacteremic and nonbacteremic patients with infection. Arch Intern Med. 1987 ; 147 (2). 232-236
6. Taylor B, Sibbald WJ, Edmonds MW, Holliday RL, Williams C. Ionized hypocalcemia in critically ill patients with sepsis. Can J Surg. 1978 ; 21 (5). 429-433
7. Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis. Ann Intern Med. 1987 ; 107 (1). 36-41
8. Lind L, Carlstedt F, Rastad J, et al. Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med. 2000 ; 28 (1). 93-99
9. Canaff L, Hendy GN. Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elements. J Biol Chem. 2005 ; 280 (14). 14177-14188
10. Canaff L, Zhou X, Hendy GN. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem. 2008 ; 283 (20). 13586-13600
11. Kelly A, Levine M Pediatric Practice: Endocrinology. Kappy G Allen D, ed. New York, NY: McGraw-Hill ; 2010 :
12. Moore EW. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. J Clin Invest. 1970 ; 49 (2). 318-334
13. Zaloga GP, Willey S, Tomasic P, Chernow B. Free fatty acids alter calcium binding: a cause for misinterpretation of serum calcium values and hypocalcemia in critical illness. J Clin Endocrinol Metab. 1987 ; 64 (5). 1010-1014
14. Berry EM, Gupta MM, Turner SJ, Burns RR. Variation in plasma calcium with induced changes in plasma specific gravity, total protein, and albumin. Br Med J. 1973 ; 4 (5893). 640-643
15. Brown EM, Pollak M, Hebert SC. Sensing of extracellular Ca2+ by parathyroid and kidney cells: cloning and characterization of an extracellular Ca(2+)-sensing receptor. Am J Kidney Dis. 1995 ; 25 (3). 506-513
16. Almaden Y, Hernandez A, Torregrosa V, et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol. 1998 ; 9 (10). 1845-1852
17. Rodriguez M, Almaden Y, Hernandez A, Torres A. Effect of phosphate on the parathyroid gland: direct and indirect?. Curr Opin Nephrol Hypertens. 1996 ; 5 (4). 321-328
18. Matsumoto T. Magnesium deficiency and parathyroid function. Intern Med. 1995 ; 34: 603-604
19. Klein GL. The interaction between burn injury and vitamin D metabolism and consequences for the patient. Curr Clin Pharmacol. 2008 ; 3 (3). 204-210
20. Murphey ED, Chattopadhyay N, Bai M, et al. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit Care Med. 2000 ; 28 (12). 3885-3890
21. van Abel M, Hoenderop JG, Bindels RJ. The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease. Naunyn Schmiedebergs Arch Pharmacol. 2005 ; 371 (14). 295-306
22. Tenenhouse HS. Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. Annu Rev Nutr. 2005 ; 25: 197-214
23. Bowe AE, Finnegan R, Jan de Beur SM, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun. 2001 ; 284 (4). 977-981
24. Saito H, Maeda A, Ohtomo S, et al. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2005 ; 280 (4). 2543-2549
25. Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004 ; 19 (3). 429-435
26. Jande SS. An electron microscopic study. Z Zellforsch Mikrosk Anat. 1972 ; 130 (4). 463-470
27. Dallas S, Bonewald L. Osteocytes play to standing room only: Meeting Report from the 30th Annual Meeting of the American society for Bone and Mineral Research. IBMS BoneKey. 2008 ; 5: 441-445
28. Huang JC, Sakata T, Pfleger LL, et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004 ; 19 (2). 235-244
29. Zaidi M, Moonga BS, Abe E. Calcitonin and bone formation: a knockout full of surprises. J Clin Invest. 2002 ; 110 (12). 1769-1771
30. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem. 2003 ; 278 (39). 38084-38093
31. DeLuca HF. Metabolism of vitamin D: current status. Am J Clin Nutr. 1976 ; 29 (11). 1258-1270
32. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci. 1972 ; 43 (3). 413-431
33. Lawson DE, Douglas J, Lean M, Sedrani S. Estimation of vitamin D3 and 25-hydroxyvitamin D3 in muscle and adipose tissue of rats and man. Clin Chim Acta. 1986 ; 157 (2). 175-181
34. Murayama A, Takeyama K, Kitanaka S, et al. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology. 1999 ; 140 (5). 2224-2231
35. Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007 ; 293 (5). F1577 - F1583
36. Lechner D, Kallay E, Cross HS. 1Alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol. 2007 ; 263 (1-2). 55-64
37. Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest. 2006 ; 116 (6). 1703-1712
38. Johnston PC, Donnelly DE, Morrison PJ, Hunter SJ. DiGeorge syndrome presenting as late onset hypocalcaemia in adulthood. Ulster Med J. 2008 ; 77 (3). 201-202
39. Kar PS, Ogoe B, Poole R, Meeking D. Di-George syndrome presenting with hypocalcaemia in adulthood: two case reports and a review. J Clin Pathol. 2005 ; 58 (6). 655-657
40. MacIsaac RJ, Heath JA, Rodda CP, et al. Role of the fetal parathyroid glands and parathyroid hormone-related protein in the regulation of placental transport of calcium, magnesium and inorganic phosphate. Reprod Fertil Dev. 1991 ; 3 (4). 447-457
41. Tsang RC, Chen IW, Friedman MA, Chen I. Neonatal parathyroid function: role of gestational age and postnatal age. J Pediatr. 1973 ; 83 (5). 728-738
42. Mallet E, Basuyau JP, Brunelle P, Devaux AM, Fessard C. Neonatal parathyroid secretion and renal receptor maturation in premature infants. Biol Neonate. 1978 ; 33 (5-6). 304-308
43. Minagawa M, Yasuda T, Kobayashi Y, Niimi H. Transient pseudohypoparathyroidism of the neonate. Eur J Endocrinol. 1995 ; 133 (2). 151-155
44. Tsang RC, Light IJ, Sutherland JM, Kleinman LI. Possible pathogenetic factors in neonatal hypocalcemia of prematurity. The role of gestation, hyperphosphatemia, hypomagnesemia, urinary calcium loss, and parathormone responsiveness. J Pediatr. 1973 ; 82 (3). 423-429
45. Nekvasil R, Stejskal J, Tuma A. Detection of early onset neonatal hypocalcaemia in low birth weight infants by Q-Tc and Q-oTc interval measurement. Acta Paediatr Acad Sci Hung. 1980 ; 21 (4). 203-210
46. Venkataraman PS, Blick KE, Dasharathy G, Parker MK. Lowered serum Ca, blood ionized Ca, and unresponsive serum parathyroid hormone with oral glucose ingestion in infants of diabetic mothers. J Pediatr Gastroenterol Nutr. 1987 ; 6 (6). 931-935
47. Kaplan EL, Burrington JD, Klementschitsch P, Taylor J, Deftos L. Primary hyperparathyroidism, pregnancy, and neonatal hypocalcemia. Surgery. 1984 ; 96 (4). 717-722
48. Ip P. Neonatal convulsion revealing maternal hyperparathyroidism: an unusual case of late neonatal hypoparathyroidism. Arch Gynecol Obstet. 2003 ; 268 (3). 227-229
49. Venkataraman PS, Tsang RC, Greer FR, Noguchi A, Laskarzewski P, Steichen JJ. Late infantile tetany and secondary hyperparathyroidism in infants fed humanized cow milk formula. Longitudinal follow-up. Am J Dis Child. 1985 ; 139 (7). 664-668
50. Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev. 2008 ; 14 (1). 3-10
51. Cuneo BF, Driscoll DA, Gidding SS, Langman CB. Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am J Med Genet. 1997 ; 69 (1). 50-55
52. Hasegawa T, Hasegawa Y, Aso T, et al. The transition from latent to overt hypoparathyroidism in a child with CATCH 22 who showed subnormal parathyroid hormone response to ethylenediaminetetraacetic acid infusion. Eur J Pediatr. 1996 ; 155 (3). 255 -
53. Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S. A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism. J Clin Endocrinol Metab. 1999 ; 84 (10). 3792-3796
54. Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet. 1994 ; 8 (3). 303-307
55. Ding C, Buckingham B, Levine MA. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest. 2001 ; 108 (8). 1215-1220
56. Pellock JM, Behrens M, Lewis L, Holub D, Carter S, Rowland LP. Kearns-Sayre syndrome and hypoparathyroidism. Ann Neurol. 1978 ; 3 (5). 455-458
57. Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf). 1992 ; 37: 97-103
58. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet. 1997 ; 17 (4). 393-398
59. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997 ; 17 (4). 399-403
60. Bastepe M. The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol.. 2008 ; 626: 27-40
61. Levine MA, Germain-Lee E, Jan de Beur S. Genetic basis for resistance to parathyroid hormone. Horm Res. 2003 ; 60 Suppl 3: 87-95
62. Bastepe M, Frohlich LF, Hendy GN, et al. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest. 2003 ; 112 (8). 1255-1263
63. Bastepe M, Frohlich LF, Linglart A, et al. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet. 2005 ; 37 (1). 25-27
64. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002 ; 31 (2). 166-170
65. Walder RY, Landau D, Meyer P, et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet. 2002 ; 31 (2). 171-174
66. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996 ; 12: 24-30
67. Meij IC, Koenderink JB, De Jong JC, et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na+, K+-ATPase gamma-subunit. Ann NY Acad Sci. 2003 ; 986: 437-443
68. Elliott C, Newman N, Madan A. Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther. 2000 ; 67 (1). 16-21
69. Weng FL, Shults J, Leonard MB, Stallings VA, Zemel BS. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr. 2007 ; 86 (1). 150-158
70. Gordon CM, Feldman HA, Sinclair L, et al. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008 ; 162 (6). 505-512
71. Huh SY, Gordon CM. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord. 2008 ; 9: 161-170
72. Lappe JM, Davies KM, Travers-Gustafson T, Heaney RP. Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr. 2006 ; 25 (5). 395-402
73. Araujo AB, Travison TG, Esche GR, Holick MF, Chen TC, McKinlay JB. Serum 25-hydroxyvitamin D and bone mineral density among Hispanic men. Osteoporos Int. 2009 ; 20 (2). 245-255
74. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 ; 87 (4). 1080S - 1086S
75. Rajakumar K, Fernstrom JD, Holick MF, Janosky JE, Greenspan SL. Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children. Obesity (Silver Spring). 2008 ; 16: 90-95
76. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009 ; 205 (1). 255-260
77. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010 ; 10 (4). 482-496
78. Greer FR. 25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr. 2008 ; 88 (2). 529S - 533S
79. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008 ; 122 (5). 1142-1152
80. Kitanaka S, Takeyama K, Murayama A, et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med. 1998 ; 338 (10). 653-661
81. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest. 1997 ; 99 (2). 297-304
82. Cai Q, Hodgson SF, Kao PC, et al. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med. 1994 ; 330 (23). 1645-1649
83. Malabanan AO, Turner AK, Rosenberg IN, Holick MF. Oncogenic osteomalacia: clinical presentation, densitometric findings, and response to therapy. J Clin Densitom. 1998 ; 1 (1). 77-80
84. Shaikh A, Berndt T, Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol. 2008 ; 23 (8). 1203-1210
85. Riancho JA, Arjona R, Valle R, Sanz J, Gonzalez-Macias J. The clinical spectrum of hypocalcaemia associated with bone metastases. J Intern Med. 1989 ; 226 (6). 449-452
86. Szentirmai M, Constantinou C, Rainey JM, Loewenstein JE. Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer. West J Med. 1995 ; 163 (6). 577-578
87. Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med. 1988 ; 84 (4). 654-660
88. Lazar ES, Stankus N. Cinacalcet-induced hungry bone syndrome. Semin Dial. 2007 ; 20 (1). 83-85
89. Whitson HE, Lobaugh B, Lyles KW. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. Bone. 2006 ; 39 (4). 954-958
90. Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007 ; 22 Suppl 2: V100 - V104
91. Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol. 1982 ; 77 (9). 633-638
92. Imrie CW, Allam BF, Ferguson JC. Hypocalcaemia of acute pancreatitis: the effect of hypoalbuminaemia. Curr Med Res Opin. 1976 ; 4 (2). 101-116
93. Rattner DW, Napolitano LM, Corsetti J, et al. Hypocalcemia in experimental pancreatitis occurs independently of changes in serum nonesterified fatty acid levels. Int J Pancreatol. 1990 ; 6 (4). 249-262
94. McKay C, Beastall GH, Imrie CW, Baxter JN. Circulating intact parathyroid hormone levels in acute pancreatitis. Br J Surg. 1994 ; 81 (3). 357-360
95. Ammori BJ, Barclay GR, Larvin M, McMahon MJ. Hypocalcemia in patients with acute pancreatitis: a putative role for systemic endotoxin exposure. Pancreas. 2003 ; 26 (3). 213-217
96. Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med. 1988 ; 84 (2). 209-214
97. Zaloga GP. Ionized hypocalcemia during sepsis. Crit Care Med. 2000 ; 28 (1). 266-268
98. Desai TK, Carlson RW, Geheb MA. Parathyroid-vitamin D axis in critically ill patients with unexplained hypocalcemia. Kidney Int Suppl. 1987 ; 22: S225 - S228
99. Broner CW, Stidham GL, Westenkirchner DF, Tolley EA. Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients. Crit Care Med. 1990 ; 18 (9). 921-928
100. Desai TK, Carlson RW, Thill-Baharozian M, Geheb MA. A direct relationship between ionized calcium and arterial pressure among patients in an intensive care unit. Crit Care Med. 1988 ; 16 (6). 578-582
101. Ghent S, Judson MA, Rosansky SJ. Refractory hypotension associated with hypocalcemia and renal disease. Am J Kidney Dis. 1994 ; 23 (3). 430-432
102. Avsar A, Dogan A, Tavli T. A rare cause of reversible dilated cardiomyopathy: hypocalcemia. Echocardiography. 2004 ; 21 (7). 609-612
103. Sung JK, Kim JY, Ryu DW, et al. A case of hypocalcemia-induced dilated cardiomyopathy. J Cardiovasc Ultrasound. 2010 ; 18 (1). 25-27
104. Jankowski S, Vincent JL. Calcium administration for cardiovascular support in critically ill patients: when is it indicated?. J Intensive Care Med. 1995 ; 10 (2). 91-100
105. Verma S, Khadwal A, Chopra K, Rohit M, Singhi S. Hypocalcemia nutritional rickets: a curable cause of dilated cardiomyopathy. J Trop Pediatr. 2011 ; 57 (2). 126-128
106. Brown J, Nunez S, Russell M, Spurney C. Hypocalcemic rickets and dilated cardiomyopathy: case reports and review of literature. Pediatr Cardiol. 2009 ; 30 (6). 818-823
107. Bartoszewska M, Kamboj M, Patel DR. Vitamin D, muscle function, and exercise performance. Pediatr Clin North Am. 2010 ; 57 (3). 849-861
108. Schubert L, DeLuca HF. Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys. 2010 ; 500 (2). 157-161
109. Malcolm DS, Zaloga GP, Holaday JW. Calcium administration increases the mortality of endotoxic shock in rats. Crit Care Med. 1989 ; 17 (9). 900-903
110. Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008 ; 4: CD006163
111. Part 10: pediatric advanced life support. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation. 2000 ; 102 (8 Suppl). I291 - I342
112. Srinivasan V, Morris MC, Helfaer MA, Berg RA, Nadkarni VM. Calcium use during in-hospital pediatric cardiopulmonary resuscitation: a report from the National Registry of Cardiopulmonary Resuscitation. Pediatrics. 2008 ; 121 (5). e1144 - e1151
113. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric advanced life support. Pediatrics. 2006 ; 117: 1005-1028
114. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 ; 36 (1). 296-327
115. Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol. 2003 ; 5 (12). 1051-1061
116. Mody I, MacDonald JF. NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release. Trends Pharmacol Sci. 1995 ; 16 (10). 356-359
117. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2000 ; 23 (5). 222-229
118. Xu K, Tavernarakis N, Driscoll M. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron. 2001 ; 31 (6). 957-971
119. Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium. 2010 ; 47 (2). 122-129
120. Murgia M, Giorgi C, Pinton P, Rizzuto R. Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling. J Mol Cell Cardiol. 2009 ; 46 (6). 781-788